Pre-surgical ⁶⁸Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Authors

Loic Djaileb

UCLA Ahmanson Translational Theranostics Division, LOS Angeles, CA

Loic Djaileb , Wesley Robert Armstrong , Daniel Thompson , Andrei Gafita , Andrea Farolfi , Tristan Grogan , Matthew R. Cooperberg , Peter Carroll , Samuel L. Washington III, Robert Evan Reiter , Matthias Eiber , Ken Herrmann , Wolfgang P. Fendler , Johannes Czernin , Thomas A. Hope , Jeremie Calais

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT03368547

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5090)

DOI

10.1200/JCO.2023.41.16_suppl.5090

Abstract #

5090

Poster Bd #

184

Abstract Disclosures

FEATURED

Pre-surgical ⁶⁸Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Authors

Loic Djaileb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.